2022
DOI: 10.1002/pro.4324
|View full text |Cite
|
Sign up to set email alerts
|

Examining the mechanistic relationship of APC/CCDH1 and its interphase inhibitor EMI1

Abstract: Proper protein destruction by the ubiquitin (Ub)-proteasome system is vital for a faithful cell cycle. Hence, the activity of Ub ligases is tightly controlled. The Anaphase-Promoting Complex/Cyclosome (APC/C) is a 1.2 MDa Ub ligase responsible for mitotic progression and G1 maintenance. At the G1/S transition, the APC/C is inhibited by EMI1 to prevent APC/C-dependent polyubiquitination of cell cycle effectors. EMI1 uses several interaction motifs to block the recruitment of APC/C substrates as well as the APC/… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 56 publications
(192 reference statements)
0
1
0
Order By: Relevance
“…Based on their Ub transfer mechanisms, E3 ligases are classified as homologous to E6AP carboxyl terminus (HECT), RING-between-RING (RBR) and really interesting new gene (RING) proteins. There are over 600 RING-type E3 ligases and only some of them, such as the homodimeric IDOL [8,9] , the BRCA1/BARD1 heterodimer [10][11][12] , and the anaphase promoting complex/cyclosome (APC/C) [13][14][15] have been well characterised and validated as potential drug targets [16,17] . These findings stress the importance that the functional consequences of ubiquitination mediated by RING-type E3 ligases have and that there is a need to systematically characterise E3 ligases in order to understand their roles in signalling pathways.…”
Section: Introductionmentioning
confidence: 99%
“…Based on their Ub transfer mechanisms, E3 ligases are classified as homologous to E6AP carboxyl terminus (HECT), RING-between-RING (RBR) and really interesting new gene (RING) proteins. There are over 600 RING-type E3 ligases and only some of them, such as the homodimeric IDOL [8,9] , the BRCA1/BARD1 heterodimer [10][11][12] , and the anaphase promoting complex/cyclosome (APC/C) [13][14][15] have been well characterised and validated as potential drug targets [16,17] . These findings stress the importance that the functional consequences of ubiquitination mediated by RING-type E3 ligases have and that there is a need to systematically characterise E3 ligases in order to understand their roles in signalling pathways.…”
Section: Introductionmentioning
confidence: 99%